Browsing by Subject Neoplasm Metastasis

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 46  next >
Issue DateTitleAuthor(s)
2017A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.
2016Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.
2016-01-19Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis.
2017Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
2015-04-29Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.
2017Characterization of three-dimensional cancer cell migration in mixed collagen-Matrigel scaffolds using microfluidics and image analysis.
2018Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases.
2017-04-18Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.
2017-12Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.
2015-05-14EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination.
2017EMT: Present and future in clinical oncology.Santamaria, Patricia G; Moreno-Bueno, Gema; Portillo, Francisco; Cano, Amparo
2015-12-01Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
2015-12Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital polymerase chain reaction: Circulating-free DNA a powerful tool for biomarker testing in advance disease.
2017-07Impact of locally advanced or metastatic prostate cancer on the quality of life.
2016-02-22Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
2015-01-01Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database.
2017Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
2017Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.
2017-02Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy.
2017Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.